San Francisco: Neuralink the brain computer interface company founded by Elon Musk plans to begin high volume production of its implantable devices by 2026 marking a major step in its efforts to bring the technology to more patients.
Musk said the company aims to scale up manufacturing of its brain interface devices and move towards an almost fully automated surgical process for implanting them. He shared the update on social media as Neuralink continues early human trials.
The tiny implant is designed to help people with paralysis or severe neurological conditions control computers and other digital devices using their thoughts. The technology works by reading brain signals through implanted electrodes and translating them into actions on a screen.
Neuralink began human testing in 2024 after receiving approval from US regulators following earlier safety concerns. Since then the company has slowly expanded its trials. By late 2025 about 12 people had received the implant according to earlier disclosures by the company.
In June last year Neuralink raised around 650 million dollars in new funding which is expected to support its research manufacturing and clinical work. The company says its long term goal is to restore independence to people with conditions such as spinal cord injuries.
Experts say that moving to high volume production would be a significant shift for Neuralink taking it beyond experimental trials and closer to broader medical use. However they also note that large scale deployment will depend on long term safety results and regulatory approvals.
Neuralink is one of several companies working on brain computer interfaces but it has drawn particular attention due to Musk’s high profile and ambitious timelines. If the plans succeed 2026 could become a turning point for the future of brain implant technology.
The announcement was first reported by Reuters and reflects Neuralink’s confidence as it pushes ahead with one of the most closely watched medical technologies in development.